About the Enterprise
The Global HIV Vaccine Enterprise is an alliance of independent organizations around the world dedicated to accelerating the development of a preventive HIV vaccine through:
- A shared Scientific Strategic Plan: Implementing a strategic plan for HIV vaccine research that spans vaccine discovery to development and access
- Increased resources: Mobilizing significant new funding to achieve the Scientific Strategic Plan and grow the field of HIV vaccine research and development
- Greater collaboration: In keeping with the intent of the Scientific Strategic Plan, promoting more efficient, faster ways for researchers to share successes and failures and avoid duplication of efforts
The search for a safe and effective HIV vaccine has progressed further and faster in the last few years than at any time since the epidemic began. This new and highly promising era in research is a result of the outstanding achievements of Enterprise stakeholders, many of which are featured in this new report from the Global HIV Vaccine Enterprise.
We thank the funders, scientists, advocates and trial volunteers for supporting the goals and ideals of the Global HIV Vaccine Enterprise and for your commitments to working together to end the HIV/AIDS pandemic.